Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate

Journal of Controlled Release

Volumn 192, Issue , 2014, Pages 122-130

  Lee, Min Sang ^a   Lee, Jung Eun ^a   Byun, Eunkyoung ^b   Kim, Nak Won ^a   Lee, Kyuri ^a   Lee, Haeshin ^b   Sim, Sang Jun ^c   Lee, Doo Sung ^a   Jeong, Ji Hoon ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Korea University   (South Korea)

Author keywords

3,4 Dihydroxy l phenylalanine; Calcium phosphate nanoparticle; Gene delivery; Hyaluronic acid; Targeted delivery

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; CALCIUM PHOSPHATE; GENE TRANSFER; HYALURONIC ACID; MOLECULAR BIOLOGY; RNA; TUMORS;

3 ,4-DIHYDROXY-L-PHENYLALANINE; CALCIUM PHOSPHATE NANOPARTICLES; COLLOIDAL STABILITY; ENZYMATIC DEGRADATION; GENE DELIVERY; SYSTEMIC ADMINISTRATION; TARGETED CANCER THERAPY; TARGETED DELIVERY;

NANOPARTICLES; HYALURONIC ACID;

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CALCIUM PHOSPHATE; HYALURONIC ACID; NANOPARTICLE; SMALL INTERFERING RNA; 3,4 DIHYDROXY PHENYLALANINE; NANOCARRIER; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG; DOPA;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMINERALIZATION; CANCER GENE THERAPY; CONFOCAL MICROSCOPY; CONJUGATE; CONTROLLED STUDY; CYTOTOXICITY; DENSITY; ENZYMATIC DEGRADATION; FEMALE; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; LIVER CELL; MOLECULARLY TARGETED THERAPY; MOUSE; MTT ASSAY; NANOENCAPSULATION; NONHUMAN; OSMOTIC PRESSURE; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE DRUG DOSE; SYNTHESIS; TUMOR XENOGRAFT; ANIMAL TISSUE; CELL VIABILITY; COLON CARCINOMA; GENE TARGETING; PARTICLE SIZE; SOLID TUMOR; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENETICS; NUDE MOUSE; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CALCIUM PHOSPHATES; CELL LINE, TUMOR; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; HYALURONIC ACID; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84905061755     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.049     Document Type: Article

References (36)

1. M. Okazaki, Y. Yoshida, S. Yamaguchi, M. Kaneno, and J.C. Elliott Affinity binding phenomena of DNA onto apatite crystals Biomaterials 22 2001 2459 2464
2. M. Epple, K. Ganesan, R. Heumann, J. Klesing, A. Kovtun, S. Neumann, and V. Sokolova Application of calcium phosphate nanoparticles in biomedicine J. Mater. Chem. 20 2010 18 23
3. E.V. Giger, J. Puigmarti-Luis, R. Schlatter, B. Castagner, P.S. Dittrich, and J.C. Leroux Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles J. Control. Release 150 2011 87 93
4. Y. Kakizawa, S. Furukawa, and K. Kataoka Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery J. Control. Release 97 2004 345 356
5. Y. Kakizawa, S. Furukawa, A. Ishii, and K. Kataoka Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer J. Control. Release 111 2006 368 370
6. E.V. Giger, B. Castagner, J. Raikkonen, J. Monkkonen, and J.C. Leroux siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators Adv. Health Mater. 2 2013 134 144
7. M.Z. Zhang, A. Ishii, N. Nishiyama, S. Matsumoto, T. Ishii, Y. Yamasaki, and K. Kataoka PEGylated calcium phosphate nanocomposites as smart environment-sensitive carriers for siRNA delivery Adv. Mater. 21 2009 3520 3525
8. J. Li, Y.C. Chen, Y.C. Tseng, S. Mozumdar, and L. Huang Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery J. Control. Release 142 2010 416 421
9. J. Li, Y. Yang, and L. Huang Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor J. Control. Release 158 2012 108 114
10. K. Lee, M.H. Oh, M.S. Lee, Y.S. Nam, T.G. Park, and J.H. Jeong Stabilized calcium phosphate nano-aggregates using a dopa-chitosan conjugate for gene delivery Int. J. Pharm. 445 2013 196 202
11. N. Holten-Andersen, T.E. Mates, M.S. Toprak, G.D. Stucky, F.W. Zok, and J.H. Waite Metals and the integrity of a biological coating: the cuticle of mussel byssus Langmuir 25 2009 3323 3326
12. J. Ryu, S.H. Ku, H. Lee, and C.B. Park Mussel-inspired polydopamine coating as a universal route to hydroxyapatite crystallization Adv. Funct. Mater. 20 2010 2132 2139
13. H. Lee, B.P. Lee, and P.B. Messersmith A reversible wet/dry adhesive inspired by mussels and geckos Nature 448 2007 338 341
14. W.M. Chirdon, W.J. O'Brien, and R.E. Robertson Adsorption of catechol and comparative solutes on hydroxyapatite J. Biomed. Mater. Res. B Appl. Biomater. 66 2003 532 538
15. E.J. Oh, K. Park, K.S. Kim, J. Kim, J.A. Yang, J.H. Kong, M.Y. Lee, A.S. Hoffman, and S.K. Hahn Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives J. Control. Release 141 2010 2 12
16. T.C. Laurent Biochemistry of hyaluronan Acta Otolaryngol. Suppl. 442 1987 7 24
17. J. Entwistle, C.L. Hall, and E.A. Turley HA receptors: regulators of signalling to the cytoskeleton J. Cell. Biochem. 61 1996 569 577
18. A. Aruffo, I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed CD44 is the principal cell surface receptor for hyaluronate Cell 61 1990 1303 1313
19. Q. Hua, C.B. Knudson, and W. Knudson Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis J. Cell Sci. 106 Pt 1 1993 365 375
20. R.E. Eliaz, and F.C. Szoka Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells Cancer Res. 61 2001 2592 2601
21. S.Y. Han, H.S. Han, S.C. Lee, Y.M. Kang, I.S. Kim, and J.H. Park Mineralized hyaluronic acid nanoparticles as a robust drug carrier J. Mater. Chem. 21 2011 7996 8001
22. H. Lee, H. Mok, S. Lee, Y.K. Oh, and T.G. Park Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels J. Control. Release 119 2007 245 252
23. Y.X. Wang, Z.X. Xu, R. Zhang, W.Y. Li, L. Yang, and Q.L. Hu A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity Colloid Surf. B 84 2011 259 266
24. F. Pittella, K. Miyata, Y. Maeda, T. Suma, S. Watanabe, Q. Chen, R.J. Christie, K. Osada, N. Nishiyama, and K. Kataoka Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge- conversional polymer hybrid nanoparticles J. Control. Release 161 2012 868 874
25. R. Racine, and M.E. Mummert Hyaluronan Endocytosis: Mechanisms of Uptake and Biological Functions 2012 InTech Rijeka
26. R.E. Eliaz, S. Nir, and F.C. Szoka Interactions of hyaluronan-targeted liposomes with cultured cells: modeling of binding and endocytosis Liposomes, Pt D 387 2004 16 33
27. L. Contreras-Ruiz, M. de la Fuente, J.E. Parraga, A. Lopez-Garcia, I. Fernandez, B. Seijo, A. Sanchez, M. Calonge, and Y. Diebold Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells Mol. Vis. 17 2011 279 290
28. K. Park, M.Y. Lee, K.S. Kim, and S.K. Hahn Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate Biomaterials 31 2010 5258 5265
29. G. Jiang, K. Park, J. Kim, K.S. Kim, E.J. Oh, H.G. Kang, S.E. Han, Y.K. Oh, T.G. Park, and S.K. Hahn Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA Biopolymers 89 2008 635 642
30. H.Y. Yoon, H.R. Kim, G. Saravanakumar, R. Heo, S.Y. Chae, W. Um, K. Kim, I.C. Kwon, J.Y. Lee, D.S. Lee, J.C. Park, and J.H. Park Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting J. Control. Release 172 2013 653 661
31. A. Sorkin, and M. von Zastrow Signal transduction and endocytosis: close encounters of many kinds Nat. Rev. Mol. Cell Biol. 3 2002 600 614
32. H.S. Han, J. Lee, H.R. Kim, S.Y. Chae, M. Kim, G. Saravanakumar, H.Y. Yoon, D.G. You, H. Ko, K. Kim, I.C. Kwon, J.C. Park, and J.H. Park Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo J. Control. Release 168 2013 105 114
33. T.G. Park, J.H. Jeong, and S.W. Kim Current status of polymeric gene delivery systems Adv. Drug Deliv. Rev. 58 2006 467 486
34. V.M. Platt, and F.C. Szoka Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor Mol. Pharm. 5 2008 474 486
35. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
36. S. Komarova, J. Roth, R. Alvarez, D.T. Curiel, and L. Pereboeva Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor J. Ovarian Res. 3 2010